期刊文献+

他扎罗汀凝胶治疗扁平疣 脂溢性角化病 毛发苔藓的疗效观察 被引量:2

Observaiton in Efficacy of Taiarotene Gel in Treating Verruca Plana,Keratosis Seborrheica and Lichen Pilaris
下载PDF
导出
摘要 目的:观察0.05%他扎罗汀凝胶治疗扁平疣、脂溢性角化病、毛发苔藓的疗效。方法:治疗组包括35例扁平疣、33例脂溢性角化病、11例毛发苔藓均使用0.05%他扎罗汀凝胶外涂于面部及身体左侧之皮损处,每晚1次;对照组为以上所有患者进行自身对照外用传统推荐疗法之软膏,即5%5-氟尿嘧啶或20%鱼肝油软膏于身体右侧之皮损,每日2次,两组均连续用药至8周末进行判效。结果:治疗组有效率分别为80.0%、78.8%、72.7%,对照组分别为54.3%、48.5%、18.2%,疗效经统计学比较均有差异。结论:0.05%他扎罗汀凝胶治疗扁平疣、脂溢性角化病、毛发苔藓疗效确切,安全可靠。 Objective: To observe the efficacy of taiarotene gel in concentration of 0.05 % in treating verruca plana, keratosis seborrheica and lichen pilaris. Methods: 35 cases of verruca plana, 33 cases of keratosis seborrheica and 11 eases of lichen pilaris were concluded in treatment group with 0.05 % of taiaratene gel once every night. Subjects in control group were treated with routine ointment including 5 % of 5 - FU and 20 % of cod liver oil ointment twice daily. The effect of medication for 8 weeks were evaluated in both groups. Results:The effective rate was respectively 80.0%, 78.8%and 72.7% in treatment group, 54.4%, 48.5% and 18.2% in control group, the difference was statistically significant. Conclusion: 0.05% of taiaratene gel is effective and safe in treating verruca plana, keratosis seborrheica and lichen pilaris.
出处 《内蒙古医学杂志》 2007年第10期1202-1204,共3页 Inner Mongolia Medical Journal
关键词 他扎罗汀凝胶 扁平疣 脂溢性角化病 毛发苔藓 Taiarotene gel Verruca plana Keratosis seborrheica Lichen pilaris
  • 相关文献

参考文献4

  • 1Weinstein GD, Krueger GG, Lowe IVJ, et al. Tazarotene gel. a new retinoid, for topical therapy of psoriasis: vehicle - controlled study of safety, efficacy, and duration of therapeutic effect [J ]. JAm Acad Dermatol, 1997, 37(1) :85 - 92.
  • 2高春芳,顾军,郑茂荣,阎明.他扎罗汀对角质形成细胞体外增殖及分泌转化生长因子β1的影响[J].临床皮肤科杂志,2002,31(12):751-753. 被引量:4
  • 3Pietenpol JA, Stein RW, Moran E, et al. TGF - β1 inhibition of c -myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains [ J ]. Cell, 1990, 61(5):777- 785.
  • 4Zouboulis CC. Retionid which dermatological in dications will benefit in the near future. [J ]. Skin Pharmacol Appl Skin Pharmacol, 2001,14(5):303 - 15.

二级参考文献9

  • 1[1]Chandraratna RA. Tazarotene--first of a new generation of receptor-selective retinoids[J]. Br J Dermatol, 1996, 135 (Suppl 49):18-25.
  • 2[2]Weinstein GD, Krueger GG, Lowe NJ, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect [J]. J Am Acad Dermatol, 1997,37(1): 85-92.
  • 3[3]Pietenpol JA, Stein RW, Moran E, et al. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains [J]. Cell,1990,61(5):777-785.
  • 4[4]Smith EL, Walworth NC, Holick MF. Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions[J]. J Invest Dermatol, 1986,86(6):709-714.
  • 5[5]Wilkinson DI,Theeuwes M J, Farber EM .Never growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes:a comparison with epidermal growth factor [J].Exp Dermatol, 1994,3(5):239-245.
  • 6[6]Nagpal S, Patel S, Asano AT,et al.Tazarotene-induced gene 1(TIG1), a novel retinoic acid receptor-responsive gene in skin [J].J Invest Dermatol,1996,106(2): 269-274.
  • 7[7]Nagpal S,Patel S, Jacobe H,et al. Tazarotene-induced gene 2(TIG2), a novel retinoid-responsive gene in skin [J]. J Invest Dermatol, 1997,109(1): 91-95.
  • 8[8]Duvic M,Nagpal S,Asano AT,et al. Molecular mechanisms of tazarotene action in psoriasis [J]. J Am Acad Dermatol,1997,37(2Pt 3): S18-S24.
  • 9[9]Yan S, Krebs S, Leister KJ, et al. Perturbation of EGF-activated MEK1 and PKB signal pathways by TGF-betal correlates with perturbation of EGF-induced cyclin D1 and DNA synthesis by TGF-betal in C3H 10T1/2 cells[J]. J Cell Physiol, 2000,185(1):107-116.

共引文献3

同被引文献33

  • 1常有军,徐嘉,潘福琼.调Q-开关翠绿宝石激光治疗脂溢性角化病121例临床疗效观察[J].中国激光医学杂志,2005,14(5):313-315. 被引量:11
  • 2梅册芳,林宝珠.脂溢性角化病的研究进展[J].国际皮肤性病学杂志,2006,32(3):174-176. 被引量:3
  • 3蒋游晖,陈宏.Q开关红宝石激光治疗皮肤色素性损害的临床观察[J].中国中西医结合皮肤性病学杂志,2007,6(2):109-110. 被引量:7
  • 4ASAGAMI C,MUTO M,HIROTA 丁,et al. Antitumoreffects of 1,25 dihydroxyvitamin D3〔1,25 (OH) 2D3〕inseborrheic keratosis [J]. Invest Dermatol Symp Proc,1996(1):94-96.
  • 5MITSUHASHI Y. New aspects on vitamin D3ointment;treatment of senile warts withtopical application of activeforms of vitaminD [J]. Clin. Calcium, 2004 ( 14 ):141-144.
  • 6HIRAISHI Y,NAKAGAWA T,QUAN Y S,et al. Per-formance and characteristics evaluation of a sodium hya-luronatebased microneedle patch for a transcutaneousdrug delivery systemQ], Int. J. Pharm,2013(441) :570-579.
  • 7HIRASHI Y,HIROBE SJKOKA H,et al. Developmentof a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treat-ment and safety study in humans [J]. Journal of Con-trolled Release,2013(171) ;93-103.
  • 8CHUN E Y,LEE J B,LEE K H. FoKcal trichloroaceticacid peel method for benign pigmented lesions in dark-skinned patients[J]. Dermatolsurg, 2004, 30(4 Pt 1):512-516.
  • 9桑海霞.化学剥脱术治疗面部皮肤病2000例临床体会:第八届东南亚地区医学美容学术大会论文集[C].武汉:中国美容医学,2009 :125-126.
  • 10陈艳华.570nm强脉冲光治疗脂溢性角化病40例疗效观察[J].医学美学美容(中旬刊),2013(7):(缺页码,请补上)-.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部